✦ LIBER ✦

Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesothelioma

✍ Scribed by Edward K. Mbidde; Stephen J. Harland; A. Hilary Calvert; Ian E. Smith

Publisher: Springer
Year: 1986
Tongue: English
Weight: 228 KB
Volume: 18
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00273404

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine combined with carboplatin in

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma : A multicentric Phase II study

✍ Adolfo G. Favaretto; Savina M. L. Aversa; Adriano Paccagnella; Vincenzo De Pangh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND Malignant pleural mesothelioma (MPM) is increasing rapidly worldwide. Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated.

A phase II study of the platinum analogu

A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma

✍ Brian M. J. Cantwell; C. R. Franks; Adrian L. Harris 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 257 KB

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo

A phase II trial of carboplatin in patie

A phase II trial of carboplatin in patients with advanced APUD tumors

✍ Leonard Saltz; Gregory Lauwers; Jill Wiseberg; David Kelsen 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB 👁 2 views

A phase II study of m-AMSA in patients w

A phase II study of m-AMSA in patients with malignant mesothelioma

✍ Geoffrey Falkson; Daniel A. Vorobiof; Harvey J. Lerner 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 330 KB

Cisplatin in combination with irinotecan

Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma : A pilot phase II clinical trial and pharmacokinetic profile

✍ Takashi Nakano; A. Philippe Chahinian; Miho Shinjo; Naoki Togawa; Atsushi Tonomu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

The purpose of this study was to assess the efficacy and toxicity of a combination of cisplatin and irinotecan (CPT-11) in the treatment of patients with malignant pleural mesothelioma and to characterize the pharmacokinetic profiles of CPT-11 and its active metabolite, 7-ethyl-10-hydroxycamptotheci